Compare ProShares UltraPro Short QQQ ETF (SQQQ) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ProShares UltraPro Short QQQ ETF vs Tempus AI — how do they compare? ProShares UltraPro Short QQQ ETF trades at $37.82, while Tempus AI trades at $55.5 (market cap $9.93B). The key difference: Tempus AI is trading nearer its 52-week high, ProShares UltraPro Short QQQ ETF nearer its low. Which is the better fit depends on your goals.
| SQQQ | TEM | |
|---|---|---|
Sector | Leveraged / Inverse | Broad Market / Factor |
52-Week High | $92.95 | $103.25 |
52-Week Low | $36.31 | $41.55 |
Market Cap | — | $9.93B |
Enterprise Value | — | $10.56B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SQQQ, the ProShares UltraPro Short QQQ ETF, trades at $37.4, down 3.36% today, reflecting its bearish inverse leverage against the Nasdaq-100. Technical indicators are predominantly bearish, with moving averages signaling strong sell pressure, while oscillators remain neutral. The ETF is designed for short-term tactical hedging against tech declines, not long-term holding, due to daily reset mechanics that can erode value over time.
The outlook for SQQQ is highly speculative, offering potential gains only during sustained Nasdaq-100 downturns. Key risks include volatility decay from leverage, timing challenges, and the structural erosion documented since inception. It serves as a tactical tool for hedging, not a core investment, with success dependent on precise market timing.
Tempus AI (TEM) trades at $52.05, up 12.86% in 24 hours, reflecting strong momentum after Q2 2026 earnings beat revenue estimates and raised 2026 sales guidance. The stock is technically bullish with moving averages supporting upside, while fundamentals show revenue growth to $1.4 billion in 2026 but persistent net losses. Recent news highlights expansion through the Personalis acquisition and AI-driven precision medicine advancements.
Outlook: Growth prospects are robust with AI adoption in healthcare and strategic deals, but high valuation ratios and negative profitability pose risks. Analysts are bullish with a $61.57 consensus target, though cash burn and competitive pressures require monitoring for sustained investor confidence.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ProShares UltraPro Short QQQ ETF
SQQQ is a leveraged inverse ETF that seeks daily investment results, before fees and expenses, that correspond to three times the inverse (-3x) of the daily performance of the Nasdaq-100 Index. It is a tactical trading tool designed for sophisticated investors to profit from or hedge against declines in large-cap technology and growth stocks. Due to its daily reset and the effects of compounding, it is intended for short-term use and carries significant risk if held during periods of high market volatility.
Read more on SQQQ →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
